-
-
AVMAPKI-FAKZYNJA
- QTY 66
- 0.8-200 MG
- COMBO. PKG
- Near 77381
AVUTOMETINIB; DEFACTINIB (a VUE toe ME ti nib; dee FAK ti nib) treats ovarian cancer. It works by blocking a protein that causes cancer cells to grow and multiply. This helps to slow or stop the spread of cancer cells.
Change Location
Set Price Drop Alert for:
AVMAPKI-FAKZYNJA
- QTY 66
- 0.8-200 MG
- COMBO. PKG
What does Supply mean?
If your selected quantity is intended to last longer than one month, please recheck the price using the 3-months supply option. In some cases, the estimated drug price may vary depending on the supply duration.
More Ways to Save On:
AVMAPKI-FAKZYNJA
- QTY 66
- 0.8-200 MG
- COMBO. PKG
You may find alternative ways to save with this medication. Talk to your pharmacist about the potential option(s) noted below.
Medicine Chest
AVMAPKI-FAKZYNJA Lifestyle Interactions
-
Defactinib 200mg, Oral tablet
• Interaction: Grapefruit juice• Severity: Major• Notes for Consumers: Do not drink grapefruit juice or eat grapefruit while taking this medication. Grapefruit may alter the effects of your medication. Serious side effects may occur. Contact your care team right away if you experience new or worsening side effects.• Notes for Professionals: Advise patients to avoid grapefruit and grapefruit juice during defactinib treatment due to the risk of increased defactinib exposure and adverse reactions. Defactinib is a CYP3A substrate and grapefruit juice is a CYP3A inhibitor.
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment. Drug information is sourced from GSDD (Gold Standard Drug Database ) provided by Elsevier.
